Meet Portia Combow, who has battled Hidradenitis Suppurativa (HS) for nearly two decades. Portia has been generous enough to share her experiences around the stigma, her long journey to diagnosis, as well as her own discovery of disease management strategies. At Thalocan we work to improve the process of disease assessment in clinical research, the patient experience informs all…
Accelerating Scale Validation with TAVOS: A Game Changer for Disease Assessment Rater scales have become the standard for measuring endpoints in dermatology clinical research. These instruments are now essential tools for evaluating efficacy in inflammatory skin disease trials. Yet, the process of developing and validating scales remains anything but standard. It is labor-intensive, costly, and…
Looking forward to the program at the Health Equity Congress 2025! The topic is so important in clinical care as well as across the clinical research space. Thank you Kisaco Research!UPDATE: Check out our HEC webinar here.
We have had extraordinary luck in assembling the team we have here at Thalocan. The streak continues today as we welcome @TeresaDeHaemer to the team, I had the pleasure of working with Teresa in my previous life and was impressed by her dedication to clients and her integrity…
